Pinpointing those at high risk of developing RA, such as first-degree relatives of patients with RA, ACPA/RF-positive asymptomatic individuals, or patients with clinically suspicious arthralgia, is particularly relevant. The gene discussed is PRTN3; the disease is rheumatoid arthritis.